Andrew Fisher Verona Pharma PLC (VRNA) insider trading activity

Andrew Fisher is General Counsel of Verona Pharma plc. Currently has a direct ownership of 359,999 shares of VRNA, which is worth approximately $32.4 Million. The most recent transaction as insider was on Jun 16, 2025, when has been sold 80,000 shares (Ordinary Shares) at a price of $11.53 per share, resulting in proceeds of $922,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 360K

20.0% 3M change

n/a 12M change

Total Value Held $32.4 Million

Andrew Fisher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 16 2025	SELL Open market or private sale	$922,400 $11.53 p/Share	80,000 Reduced 18.18%	359,999 Ordinary Shares
Jun 16 2025	BUY Exercise of conversion of derivative security	$160,799 $2.01 p/Share	80,000 Added 15.38%	439,999 Ordinary Shares
May 15 2025	SELL Open market or private sale	$685,600 $8.57 p/Share	80,000 Reduced 18.18%	359,999 Ordinary Shares
May 15 2025	BUY Exercise of conversion of derivative security	$168,800 $2.11 p/Share	80,000 Added 15.38%	439,999 Ordinary Shares
Apr 29 2025	SELL Open market or private sale	$234,126 $8.98 p/Share	26,072 Reduced 6.75%	359,993 Ordinary Shares
Apr 29 2025	BUY Exercise of conversion of derivative security	-	86,064 Added 18.23%	386,065 Ordinary Shares
Mar 19 2025	BUY Bona fide gift	-	1 Added 0.0%	300,001 Ordinary Shares
Oct 30 2024	BUY Grant, award, or other acquisition	-	300,000 Added 50.0%	300,000 Ordinary Shares

Andrew Fisher

General Counsel

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account